| Recruitment status | Completed |
| Unique ID issued by UMIN | UMIN000016103 |
| Receipt No. | R000016922 |
| Official scientific title of the study | Hemodynamic monitoring in patients undergoing high risk surgery: a survey among Japanese anesthesiologists |
| Date of disclosure of the study information | 2015/01/04 |
| Last modified on | 2016/04/09 (Ver. 4) |
| Basic information | ||
| Official scientific title of the study | Hemodynamic monitoring in patients undergoing high risk surgery: a survey among Japanese anesthesiologists | |
| Title of the study (Brief title) | Hemodynamic monitoring in patients undergoing high risk surgery: a survey among Japanese anesthesiologists | |
| Region |
|
|
| Condition | ||||
| Condition | Patients undergoing high risk surgery | |||
| Classification by specialty |
|
|||
| Classification by malignancy | Others | |||
| Genomic information | NO | |||
| Objectives | |
| Narrative objectives1 | A survey ragarding hemodynamic monitoring and management in patients undergoing high risk surgery |
| Basic objectives2 | Efficacy |
| Basic objectives -Others | |
| Trial characteristics_1 | |
| Trial characteristics_2 | |
| Developmental phase | |
| Assessment | |
| Primary outcomes | results of questionaires |
| Key secondary outcomes | |
| In outcomes field, the entry of just a few words such as "safety" or "efficiency" will not be accepted. Specify the name of outcome measures, including the time when you plan to measure. Usually, only one primary outcome is accepted. Write the other outcomes in "secondary outcomes" field. |
| Base | |
| Study type | Observational |
| Study design | |
| Basic design | |
| Randomization | |
| Randomization unit | |
| Blinding | |
| Control | |
| Stratification | |
| Dynamic allocation | |
| Institution consideration | |
| Blocking | |
| Concealment | |
| Intervention | |
| No. of arms | |
| Purpose of intervention | |
| Type of intervention | |
| Interventions/Control_1 | |
| Interventions/Control_2 | |
| Interventions/Control_3 | |
| Interventions/Control_4 | |
| Interventions/Control_5 | |
| Interventions/Control_6 | |
| Interventions/Control_7 | |
| Interventions/Control_8 | |
| Interventions/Control_9 | |
| Interventions/Control_10 | |
| In interventions field, include the details of interventions, such as duration, amount, and frequency. If the intervention includes prescription or use of medical devices, duration is required. |
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Male and Female | |||
| Key inclusion criteria | anesthesiologists | |||
| Key exclusion criteria | the subjects should agree joining this research | |||
| Target sample size | 100 | |||
| Research contact person | |
| Name of lead principal investigator | Katsuaki Tanaka |
| Organization | Osaka City University Graduate School of Medicine
|
| Division name | Department of Anesthesiology |
| Address | 1-5-7 Asahimachi, Abenoku, Osaka City, Osaka, 545-8586, Japan |
| TEL | 06-6645-2186 |
| anesth@med.osaka-cu.ac.jp | |
| Public contact | |
| Name of contact person | Katsuaki Tanaka |
| Organization | Osaka City University Graduate School of Medicine |
| Division name | Department of Anesthesiology |
| Address | 1-5-7 Asahimachi, Abenoku, Osaka City, Osaka, 545-8586, Japan |
| TEL | 06-6645-2186 |
| Homepage URL | |
| anesth@med.osaka-cu.ac.jp | |
| Sponsor | |
| Institute | Osaka City University Graduate School of Medicine |
| Institute | |
| Department | |
| Sponsor means an organization that is responsible for plan, deployment and report of the research including funding management. It doesn't mean funding agency". Therefore, all clinical trial should have the one. |
| Funding Source | |
| Organization | Osaka City University Graduate School of Medicine |
| Organization | |
| Division | |
| Category of Funding Organization | Self funding |
| Nationality of Funding Organization | |
| Other related organizations | |
| Co-sponsor | |
| Name of secondary funder(s) | |
| Secondary IDs | |
| Secondary IDs | NO |
| Study ID_1 | |
| Org. issuing International ID_1 | |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Progress | |||||||
| Recruitment status | Completed | ||||||
| Date of protocol fixation |
|
||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date | |||||||
| Date of closure to data entry | |||||||
| Date trial data considered complete | |||||||
| Date analysis concluded | |||||||
| Related information | |
| URL releasing protocol | |
| Publication of results | Unpublished |
| URL releasing results | |
| Results | |
| Other related information | questionnaires |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://upload.umin.ac.jp/cgi-bin/ctr_e/ctr_view.cgi?recptno=R000016922 |